Skip to main content
. 2022 Mar 31;12:813069. doi: 10.3389/fonc.2022.813069

Table 3.

Pathological characteristics of the patients in our study.

Characteristics LR (n = 153) HR (n = 49) P-value
Pathological staging, n (%) 0.0004
pI 53 (34.6%) 15 (30.6%)
pII 74 (48.4%) 16 (32.7%)
pIII 20 (13.1%) 14 (28.6%)
pIV 6 (3.9%) 4 (8.1%)
Histological grade, n (%) 0.0232
G1 71 (46.4%) 13 (26.5%)
G2
G3 and non-endometrial carcinoma
48 (31.4%) 17 (34.7%)
34 (22.2%) 19 (38.8%)

LR, low-risk group; HR, high-risk group. Bold type indicates statistically significant difference.